関連する実験動画

Updated: Feb 24, 2026

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
08:34

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening

Published on: October 16, 2015

10.6K

ヒト血清アルブミンの相互作用と双子体と多元体F-127バイナリ表面活性物質との結合に関する分子洞察 - マルチテクニックアプローチ

Deepti Tikariha Jangde1, Srishti Sinha2, Anjali Sinha3,4

  • 1Department of Chemistry, Acharya Panth Shri Grindh Muni Naam Saheb, Govt. P.G. College Kawardha, Hemchand Yadav Vishwavidyalaya, Durg, India.

Journal of molecular recognition : JMR
|February 22, 2026
PubMed
まとめ

この研究では,Pluronic F-127とジェミニ表面活性剤12-4(OH) -12がヒトの血清アルブミン (HSA) とどのように相互作用するかを調査しています. 混合された表面活性剤はHSAに結合し,部分的な展開と構造的変化を引き起こし,薬物投与システムに影響を及ぼします.

キーワード:
円形の二重化という概念があります.光 (fluorescence) とは,光 (fluorescence) とは,光 (fluorescence) とは,光 (fluorescence) とはヒトの血清アルブミンタンパク質・リガンドの相互作用表面活性剤の混合物です.

さらに関連する動画

Characterization of Proteins by Size-Exclusion Chromatography Coupled to Multi-Angle Light Scattering SEC-MALS10:00

Characterization of Proteins by Size-Exclusion Chromatography Coupled to Multi-Angle Light Scattering SEC-MALS

Published on: June 20, 2019

58.2K
Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of GoldIII08:26

Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of GoldIII

Published on: August 31, 2018

7.3K

関連する概念動画

Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
9.9K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
615
Drug Binding to Blood Components01:30

Drug Binding to Blood Components

When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
586
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
730